2024.12.03(Tue)-12.04(Wed)
3F, Ballroom, Le Méridien Taipei
medtex logo
Leading innovation, investing in the future
Advanced AI applications
|Regenerative medicine
|Immunotherapies
|Breakthrough drug development
|Innovative medical devices
Organized by Everbright Biofund.RBMP
Supported by National Science and Technology Council (NSTC)|National Development Council (NDC)
Speakers
Global Startups
Agenda
December 3
10:00-10:10 Opening Remark
Keynote Speech
10:10-10:50
AI-Driven Innovations and Opportunities in Drug Discovery
Keynote Speaker
Ettikan Karuppiah, Director & Technologist, NVIDIA
10:50-11:30
Advancing Generative AI in Biomedicine: Next Steps and Opportunities
Keynote Speaker
Keren Priyadarshini, Healthcare Lead, Microsoft Asia
11:30-13:00 Lunch Break
13:00-14:00【Fireside Chat】
Investing in the Future of Healthcare: Trends and Opportunities in 2025
Moderator
Charles Lin, Principal, illumina Ventures
Panelists
Robert Mittendorff, General Partner & Head of Healthcare, B Capital
Ian Chiang, Partner, Flare Capital Partners
Nate Chang, Operating Partner, Playground Global
Cheryl Cheng, Founder, Vive Collective
Pitch Session - Regenerative Medicine
14:00-14:40
  1. Tempo Therapeutics|Westbrook Weaver, Founder & CEO
  2. EyeYon|Nahum Ferera, Co-Founder & CEO
  3. EpiBone|Nina Tandon, CEO
14:40-15:10 Coffee Break
Pitch Session - Immunotherapy.Gene Therapy
15:10-16:00
  1. ImmuneBridge|Nina Horowitz, CSO
  2. Cirsium Biosciences|Jake Connors, Co-Founder & CTO
  3. Rejuvenate Bio|Daniel Oliver, Co-Founder & CEO
  4. Verlmmune|Joshua Wang, Founder & CEO
Pitch Session - New Drug Development (I)
16:00-16:40
  1. SYNCELL|Jung-Chi Liao, Founder & CEO
  2. Pharmosa Biopharm|Pei Kan, Co-Founder & CEO
  3. Coastar Therapeutics|Chongyang Luo, COO
16:40-17:30 Post-Event Networking
December 4
10:00-10:05【Opening Remark】
Pan-Chyr Yang, Vice President, IBMI
10:05-10:20【Keynote Speech】
AI in Health Technologies & Achieving Clinical Adoption
Host
Pan-Chyr Yang, Vice President, IBMI
Keynote Speaker
Zubin Daruwalla, Asia Pacific Health Industries Leader, PwC Singapore
Pitch Session - New Drug Development (II)
10:20-11:10
  1. Arbor Biotechnologies|David Cheng, CTO
  2. PRISM BioLab|Dai Takehara, President & CEO
  3. Rapafusyn Pharmaceuticals|Sean Hu, CEO
  4. Myrobalan Therapeutics|Jing Wang, Co-Founder & CEO
Pitch Session - Medical Device.Smart Healthcare
11:10-11:50
  1. HistoSonics|Josh King, Vice President of Global Market Access and Marketing
  2. Qritive|Bruno Occhipinti, CEO
  3. Niramai Health Analytix|Vicky Nanda, COO
11:50-13:00 Post-Event Networking
(This forum is by invitation only)
© EverRise Biomedical Co. Ltd. All rights reserved.
For inquiries, please email: b2b@erbio.com.tw